Stay up to date on the latest pharmacy trends and protocols with our free pharmacy continuing education courses. Our evidence-based pharmacy CME and CE offerings are perfect for ensuring you’re using only the most current, proven best practices.

Hematology/Oncology
A Comprehensive Review of Metastatic Colorectal Cancer (mCRC) Management: An Interprofessional Approach to Care
CME: 1.5
Right Treatment, Right Time: Case-Based Podcasts on MS Treatment PODCAST 1: Newly Diagnosed Relapsing MS and Treatment Considerations
Examine relevant data for choosing an appropriate DMT based on patient-specific characteristics.
CME: 0.25
HoFH – Homozygous Familial Hypercholesterolemia
Identify the signs, symptoms, and diagnostic markers of familial hypercholesterolemia
CME: 1.0
Optimizing Multiple Sclerosis Care in the General Neurology Setting
A series of case reviews that provides participants with scenarios where one or more errors, unsafe practices, or underutilization of newer therapies when appropriate have occurred.
CME: 1.0
Targeting Large B-Cell Lymphoma: Advances in Treatment
An interactive nationwide webinar focused on advances in the management of patients with diffuse large B-cell lymphoma (DLBCL).
CME: 1.0
Nontuberculous Mycobacterial Lung Disease: Strategies and Solutions for Real-World Management
Join in this interactive, case-based dialogue about the real-world management of patients with MAC-LD. The faculty provide their insights to address challenges encountered in everyday clinical practice.
CME: 1.5
Continuity in Care®: Best Practices in Immunoglobulin Therapy—Improving Quality of Life for Patients With Primary Immunodeficiency
Analyze the efficacy and safety data regarding the use of subcutaneous immunoglobulin SCIg products in patients with PI
CME: 1.5
Novel Androgen Deprivation Treatment for Advanced Prostate Cancer: Optimizing Benefits, Mitigating Risk
Develop treatment strategies incorporating patient-specific factors, including risk factors, concerns, preferences, and adherence information regarding oral vs injectable oncologic therapy in prostate cancer
CME: 1.5

Pharmacy